Retractable Technologies Inc. Files Q3 2024 10-Q
Ticker: RVP · Form: 10-Q · Filed: Nov 14, 2024 · CIK: 946563
| Field | Detail |
|---|---|
| Company | Retractable Technologies Inc (RVP) |
| Form Type | 10-Q |
| Filed Date | Nov 14, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
Related Tickers: RVP
TL;DR
RVP Q3 10-Q filed. Financials look stable, check preferred stock and retained earnings.
AI Summary
Retractable Technologies Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial positions including preferred stock, treasury stock, and retained earnings as of September 30, 2024, and comparative periods. Key financial data points from prior periods are also presented.
Why It Matters
This filing provides investors with the latest financial snapshot of Retractable Technologies Inc., crucial for understanding the company's performance and financial health.
Risk Assessment
Risk Level: low — The filing is a routine quarterly report and does not indicate any immediate or significant new risks.
Key Numbers
- 0000946563 — Central Index Key (Unique identifier for Retractable Technologies Inc.)
- TX — State of Incorporation (Legal domicile of the company.)
Key Players & Entities
- RETRACTABLE TECHNOLOGIES INC (company) — Filer
- 2024-09-30 (date) — End of reporting period
- 2024-06-30 (date) — Comparative period end
- 2023-12-31 (date) — Prior fiscal year end
FAQ
What are the specific amounts for SeriesTwoConvertibleClassBPreferredStockMember as of September 30, 2024?
The filing indicates the presence of SeriesTwoConvertibleClassBPreferredStockMember as of September 30, 2024, but specific dollar amounts are not detailed in this header section.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the SIC code for Retractable Technologies Inc.?
The Standard Industrial Classification (SIC) code is 3841, for Surgical & Medical Instruments & Apparatus.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on November 14, 2024.
What are the key financial statement components listed for the reporting period?
The filing lists components such as SeriesTwoConvertibleClassBPreferredStockMember, SeriesThreeConvertibleClassBPreferredStockMember, TreasuryStockCommonMember, RetainedEarningsMember, and AdditionalPaidInCapitalMember for the period ending September 30, 2024.
Filing Stats: 4,404 words · 18 min read · ~15 pages · Grade level 15.3 · Accepted 2024-11-14 14:32:27
Filing Documents
- tmb-20240930x10q.htm (10-Q) — 1389KB
- tmb-20240930xex31d1.htm (EX-31.1) — 14KB
- tmb-20240930xex31d2.htm (EX-31.2) — 14KB
- tmb-20240930xex32.htm (EX-32) — 8KB
- 0001558370-24-015682.txt ( ) — 6739KB
- tmb-20240930.xsd (EX-101.SCH) — 39KB
- tmb-20240930_cal.xml (EX-101.CAL) — 51KB
- tmb-20240930_def.xml (EX-101.DEF) — 144KB
- tmb-20240930_lab.xml (EX-101.LAB) — 335KB
- tmb-20240930_pre.xml (EX-101.PRE) — 239KB
- tmb-20240930x10q_htm.xml (XML) — 1491KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION Item 1.
Financial Statements
Financial Statements 1 CONDENSED BALANCE SHEETS 1 CONDENSED STATEMENTS OF OPERATIONS 2 CONDENSED STATEMENTS OF CASH FLOWS 3 CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY 4 NOTES TO CONDENSED FINANCIAL STATEMENTS 5 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 22 Item 4.
Controls and Procedures
Controls and Procedures 22
—OTHER INFORMATION
PART II—OTHER INFORMATION Item 1.
Legal Proceedings
Legal Proceedings 22 Item 1A.
Risk Factors
Risk Factors 22 Item 5. Other Information 22 Item 6. Exhibits 23
SIGNATURES
SIGNATURES 23 Table of Contents
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements. RETRACTABLE TECHNOLOGIES, INC. CONDENSED BALANCE SHEETS (unaudited) September 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 3,917,246 $ 12,667,550 Accounts receivable, net 8,674,774 10,671,721 Investments in debt and equity securities, at fair value 32,782,319 34,621,213 Inventories 21,301,008 17,581,368 Income taxes receivable 1,111,851 1,155,077 Other current assets 968,949 952,668 Total current assets 68,756,147 77,649,597 Property, plant, and equipment, net 88,936,910 93,478,521 Deferred tax asset — 8,392,030 Other assets 114,803 152,064 Total assets $ 157,807,860 $ 179,672,212 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 3,251,331 $ 4,779,035 Current portion of long-term debt 325,155 303,991 Accrued compensation 809,937 865,105 Dividends payable 1,417,437 1,417,437 Accrued royalties to shareholder 884,570 1,376,555 Other accrued liabilities 1,325,080 630,571 Income taxes payable 5,864 4,802 Total current liabilities 8,019,374 9,377,496 Other long-term liabilities 65,344,155 69,773,538 Long-term debt, net of current maturities 986,750 1,233,519 Total liabilities 74,350,279 80,384,553 Commitments and contingencies – see Note 10 Stockholders' equity: Preferred stock, $ 1 par value: Class B; authorized: 5,000,000 shares Series II, Class B 156,200 156,200 Series III, Class B 74,245 74,245 Common Stock, no par value — — Additional paid-in capital 73,160,333 73,160,333 Retained earnings 22,955,481 38,785,559 Common stock in treasury – at cost ( 12,888,678 ) ( 12,888,678 ) Total stockholders' equity 83,457,581 99,287,659 Total liabilities and stockholders' equity $ 157,807,860 $ 179,672,212 See accompanying notes to condensed unaudited financial statements 1 Table of Contents RETRACTABLE TECHNOLOGIE